# Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain

> **NCT00032097** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** motexafin gadolinium
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00032097
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032097, "Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00032097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*